Mountain ridge at sunrise

Big agency thinking at boutique agility.

Where strategy
meets the moment.

Kairos Meridian brings pharma marketing, analytics and innovation in service of impact.

Aaron Uydess, founder of Kairos Meridian, independent pharma commercial strategy and omnichannel advisor

Talk with Aaron

Start a conversation today

Aaron Uydess, founder of Kairos Meridian, independent pharma commercial strategy and omnichannel advisor

Talk with Aaron

Start a conversation today

DIRECT TO PATIENT

Patient on a telehealth video call with her doctor at home
Patient on a telehealth video call with her doctor at home
Patient on a telehealth video call with her doctor at home

Deeper dive on DTP

Planning, launching or fixing a DTP program? Start here.

See where direct-to-patient fits, how it works, the brand challenges it solves, our role, measurement and a case study.

INDUSTRY LANDSCAPE

The commercial model needs rewriting


Built for the moment the playbook stopped working.

Silent film worked until sound arrived. Video rental worked until streaming replaced it. The format before each transition wasn’t bad. It was insufficient for what came next.

These are the moments we were built for.

Commercial

33% meet or exceed

67% of pharma brands fail to meet launch expectations and sales forecasts, with 70% continuing to underperform three years post-launch.

Deloitte Center for Health Solutions, 2020

Meeting behind glass: Only 33% of pharma brands meet or exceed launch expectations, a core commercial strategy challenge

Commercial

33% meet or exceed

67% of pharma brands fail to meet launch expectations and sales forecasts, with 70% continuing to underperform three years post-launch.

Deloitte Center for Health Solutions, 2020

Meeting behind glass: Only 33% of pharma brands meet or exceed launch expectations, a core commercial strategy challenge

Omnichannel

53% HCP engagement

HCP field & digital engagement levels fell by 53% even as U.S. pharma ad spend has more than tripled to an estimated $39B.

Veeva Systems Pulse Field Trends, 2024

Clinician reviewing a tablet: HCP engagement fell 53% while U.S. pharma ad spend tripled to $39B, the pharma omnichannel gap

Omnichannel

53% HCP engagement

HCP field & digital engagement levels fell by 53% even as U.S. pharma ad spend has more than tripled to an estimated $39B.

Veeva Systems Pulse Field Trends, 2024

Clinician reviewing a tablet: HCP engagement fell 53% while U.S. pharma ad spend tripled to $39B, the pharma omnichannel gap

Direct to Patient (DTP)

50-point gap

72% said they would buy prescriptions directly from a manufacturer. Only 22% ever had. It is not a demand problem. It is a promotion problem.

Model N, 2025

Video visit: 72% of patients would buy prescriptions direct from a manufacturer, yet only 22% have: the DTP promotion gap

Direct to Patient (DTP)

50-point gap

72% said they would buy prescriptions directly from a manufacturer. Only 22% ever had. It is not a demand problem. It is a promotion problem.

Model N, 2025

Video visit: 72% of patients would buy prescriptions direct from a manufacturer, yet only 22% have: the DTP promotion gap

Patient Abandonment

98M lost new patients

98 million new therapy prescriptions were abandoned in 2023. 43 million of those were abandoned when the cost was under $10 or at no cost to the patient. Only 31% of patients were still on therapy a year later.

IQVIA, 2023

Aerial crowd: 98 million new prescriptions were abandoned in 2023 and only 31% of patients stayed on therapy a year

Patient Abandonment

98M lost new patients

98 million new therapy prescriptions were abandoned in 2023. 43 million of those were abandoned when the cost was under $10 or at no cost to the patient. Only 31% of patients were still on therapy a year later.

IQVIA, 2023

Aerial crowd: 98 million new prescriptions were abandoned in 2023 and only 31% of patients stayed on therapy a year

Innovation

50% of leaders want an overhaul

50% of global life-sciences leaders say they must completely abandon their traditional business model to enable innovation, accelerate decisions & stay competitive.

Deloitte Center for Health Solutions, 2020

Leadership team: 50% of life sciences leaders say the traditional pharma commercial model must be replaced to innovate

Innovation

50% of leaders want an overhaul

50% of global life-sciences leaders say they must completely abandon their traditional business model to enable innovation, accelerate decisions & stay competitive.

Deloitte Center for Health Solutions, 2020

Leadership team: 50% of life sciences leaders say the traditional pharma commercial model must be replaced to innovate
The work is the product. The independence is the structure. The impact is the proof.
The work is the product. The independence is the structure. The impact is the proof.
The work is the product. The independence is the structure. The impact is the proof.

OUR SERVICES

Three questions.
Three offerings.


Most firms protect the relationship by telling clients what they want to hear. Clients hire us for the opposite: the uncomfortable, on-time truth, delivered while it’s still cheap to act on. With no platform to sell and no media to mark up.

Boardroom: Devil's Advocate: independent pressure-testing of a pharma launch plan, vendor selection or diligence thesis

THE DEVIL'S ADVOCATE

Is my thinking right?

Independent challenge to an idea, decision, or recommendation already on the table from launch plans to vendor selections or a board recommendation to a diligence thesis. We pressure-test the thinking, surface what’s been assumed rather than evidenced, and name the risks the team is too close to see. We don’t replace your team, we interrogate the thinking.

Boardroom: Devil's Advocate: independent pressure-testing of a pharma launch plan, vendor selection or diligence thesis

THE DEVIL'S ADVOCATE

Is my thinking right?

Small team meeting: Consigliere: senior pharma commercial counsel on call before board meetings, pitches and key decisions

THE CONSIGLIERE

What should I do?

We are the senior commercial voice on call, before the board meeting, before the client pitch or before the decision is final. Engagements range from check-ins, ad-hoc consultations, slide content to written recommendations when the decisions warrant them. We bring a point of view, not just a critique, and stay accountable for the quality of the counsel.

Small team meeting: Consigliere: senior pharma commercial counsel on call before board meetings, pitches and key decisions

THE CONSIGLIERE

What should I do?

Team working session: Partner by Mandate: embedded senior commercial leadership for pharma brands against a written mandate

THE PARTNER BY MANDATE

Can you do it with me?

Embedded senior commercial leadership against a written mandate. Our deepest commitment to a single client during their pre-launch year, a brand’s first eighteen months or addressing mid-cycle pressure points. This is not a fractional role billed by the day but a partner accountable for the trajectory of the mandate.

Team working session: Partner by Mandate: embedded senior commercial leadership for pharma brands against a written mandate

THE PARTNER BY MANDATE

Can you do it with me?

Senior hands on your hardest work.

Most firms hand you a deck and a bill. We stay for the work. Kairos Meridian sits inside your team as strategist, program manager and analyst: shaping the plan, running it week to week and reading the numbers that show what to change. What we don’t do is sell you technology or media. No platform to push and no markup to protect, so every call we make is built around your outcome.

We serve as your strategist, growth partner, architect, innovator, catalyst, storyteller, operator, problem solver, orchestrator, activator, program manager, optimizer, analyst
  • strategist
  • growth partner
  • architect
  • innovator
  • catalyst
  • storyteller
  • operator
  • problem solver
  • orchestrator
  • activator
  • program manager
  • optimizer
  • analyst

Senior hands on your hardest work.

Most firms hand you a deck and a bill. We stay for the work. Kairos Meridian sits inside your team as strategist, program manager and analyst: shaping the plan, running it week to week and reading the numbers that show what to change. What we don’t do is sell you technology or media. No platform to push and no markup to protect, so every call we make is built around your outcome.

We serve as your strategist, growth partner, architect, innovator, catalyst, storyteller, operator, problem solver, orchestrator, activator, program manager, optimizer, analyst
  • strategist
  • growth partner
  • architect
  • innovator
  • catalyst
  • storyteller
  • operator
  • problem solver
  • orchestrator
  • activator
  • program manager
  • optimizer
  • analyst

Senior hands on your hardest work.

Most firms hand you a deck and a bill. We stay for the work. Kairos Meridian sits inside your team as strategist, program manager and analyst: shaping the plan, running it week to week and reading the numbers that show what to change. What we don’t do is sell you technology or media. No platform to push and no markup to protect, so every call we make is built around your outcome.

We serve as your strategist, growth partner, architect, innovator, catalyst, storyteller, operator, problem solver, orchestrator, activator, program manager, optimizer, analyst
  • strategist
  • growth partner
  • architect
  • innovator
  • catalyst
  • storyteller
  • operator
  • problem solver
  • orchestrator
  • activator
  • program manager
  • optimizer
  • analyst

WHY THEY CHOOSE US

Decrease waste.
Increase wins.

Most firms protect the relationship by telling clients what they want to hear. Clients hire Kairos Meridian for the opposite: the uncomfortable, on-time truth, delivered while it’s still cheap to act on. With no platform to sell and no media to mark up, the work is the product — which is exactly why it can afford to be inconvenient.

Pharmacist reviewing product data on a tablet by medication shelves, representing pharma and life sciences clients

1. Life Sciences & Pharma

Focus on impact over activity at scale

Embracing both simplicity & sophistication simultaneously

A view free from internal politics

Presenter mapping a go-to-market strategy on a whiteboard for four colleagues, representing pharma vendor clients

2. The Vendors They Use

GTM positioning & story that lands with a buyer

A candid critique of the sales narrative

A clear answer quickly, with counsel that will tell you “don’t”

Three colleagues reviewing diligence documents at a boardroom table, representing pharma-focused private equity clients

3. Private Equity

Diligence from a practitioner & subject matter expert

Spotting risk early

Exit readiness, from the commercial story

FAQ

Have questions?

Check out the FAQs

Have questions?

Check out the FAQs

Have questions?

Check out the FAQs

Aaron Uydess, founder of Kairos Meridian, independent pharma commercial strategy and omnichannel advisor

Talk with Aaron

Start a conversation today

Aaron Uydess, founder of Kairos Meridian, independent pharma commercial strategy and omnichannel advisor

Talk with Aaron

Start a conversation today

What does Kairos Meridian do?

We do the senior commercial work pharma brands need while the decisions are still open: building the strategy, sharpening the program and running it with the analytics to prove it. The work is our product.

What are your areas of expertise?

Commercial strategy in pharma & life sciences, with the deepest work in omnichannel, direct-to-patient, innovation, data and analytics.

What kind of businesses do you work with?

Small and mid-cap pharma brands in their first five years, the vendors selling into them, and the private equity firms holding related assets.

What don’t you do?

We don’t sell technology or media, and we don’t do the technical build: no media buying, campaign production or platform implementation, and no junior consultants doing the thinking. We take strategy through execution and bring the analytics to measure it, which keeps our work independent.

Are you a fractional executive service?

No. Fractional arrangements sell a percentage of someone’s time. We take interim leadership roles with a specific mandate, a defined goal, and an end date.

How do you price your projects?

Fixed fee, scoped to the question, the weight of the answer and operated with efficiency. Our pricing is not based on hours, headcount, and agency overhead.

Quiet loft office with timber beams, where a 25-minute Kairos Meridian diagnostic conversation starts

The first conversation is twenty-five minutes — a diagnostic, not a pitch.

Start a conversation today

We listen for the real problem — how you got here, what you’ve tried, what success looks like — then come back with a structured read. The gap between the call and the response is where the senior judgment gets applied.